- Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer
-
Lee JH, Kim SH, Oh SY, Lee S, Lee H, Lee HJ, Kim HJ
- KMID: 1776453
- Korean J Intern Med.
- 2013 May;28(3):314-321.
- doi: 10.3904/kjim.2013.28.3.314
BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Paclitaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer
-
Hwang J, Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Lee JJ, Kim HJ, Chung IJ
- KMID: 1785814
- J Korean Med Sci.
- 2008 Aug;23(4):586-591.
- doi: 10.3346/jkms.2008.23.4.586
This phase II study evaluated the efficacy and safety of combination chemotherapy with paclitaxel, cisplatin, and 5-fluorouracil (5-FU) in advanced gastric cancer. Patients with histologically confirmed gastric adenocarcinoma were eligible... -
- CITED
-
- Close
- SHARE
-
- Close
- Oxaliplatin and Leucovorin Plus Fluorouracil Versus Irinotecan and Leucovorin Plus Fluorouracil Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Adenocarcinoma
-
Kang SH, Kim JI, Moon HS, Kim SH, Sung JK, Lee BS, Jeong HY
- KMID: 1775923
- Korean J Gastroenterol.
- 2010 Jan;55(1):26-32.
- doi: 10.4166/kjg.2010.55.1.26
BACKGROUND/AIMS: We performed retrospective study in order to compare oxaliplatin, leucovorin, and fluorouracil (FOLFOX) versus irinotecan, leucovorin, and fluorouracil (FOLFIRI) in recurred or metastatic gastric adenocarcinoma. METHODS: We investigated 56 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Toxicities and Efficacies of the Combination Chemotherapy Regimens in Advanced Gastric Cancer Patients Who Achieved Complete Response after Chemotherapy
-
Kim YJ, Goh PG, Kim ES, Lee SY, Moon HS, Lee ES, Sung JK, Kim SH, Lee BS, Jeong HY
- KMID: 1043329
- Korean J Gastroenterol.
- 2011 Dec;58(6):311-317.
- doi: 10.4166/kjg.2011.58.6.311
BACKGROUND/AIMS: We retrospectively analyzed comparative toxicities and efficacies of chemotherapy regimens in advanced gastric cancer (AGC) patients who achieved complete response (CR) after chemotherapy. METHODS: We reviewed the medical records of... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
-
An JY, Kim HI, Cheong JH, Hyung WJ, Kim CB, Noh SH
- KMID: 2158222
- Yonsei Med J.
- 2013 Jul;54(4):888-894.
- doi: 10.3349/ymj.2013.54.4.888
PURPOSE: Although neoadjuvant therapy has been accepted as a treatment option in locally-advanced gastric cancer, its prognostic value has been difficult to evaluate. MATERIALS AND METHODS: Seventy-four gastric cancer patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer
-
Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh DY, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK
- KMID: 1785799
- J Korean Med Sci.
- 2007 Sep;22(Suppl):S115-S121.
- doi: 10.3346/jkms.2007.22.S.S115
This study was performed to evaluate the efficacy and toxicity of low-dose paclitaxel/cisplatin chemotherapy in patients with metastatic or recurrent gastric cancer that had failed 5-fluorouracil/platinum-based chemotherapy. Thirty-two patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of FOLFIRI after Failure of FOLFOX-4 in Advanced Gastric Cancer
-
Kwon HJ, Park MI, Park SJ, Moon W, Kim SE, Lee HW, Choi YJ, Kim JH
- KMID: 2373306
- Korean J Gastroenterol.
- 2015 Jul;66(1):10-16.
- doi: 10.4166/kjg.2015.66.1.10
BACKGROUND/AIMS: The purpose of this study was to investigate the efficacy and safety of irinotecan based FOLFIRI chemotherapy as a second-line treatment after failure of FOLFOX-4 chemotherapy in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Epirubicin, Cisplatin, and Protracted Venous Infusion of 5-Fluorouracil for Advanced Gastric Carcinoma
-
Cho EK, Lee WK, Lim DY, Bang SM, Park DK, Park YH, Kwon OS, Choi DJ, Shin DB, Lee JH, Lee TH
- KMID: 1101549
- J Korean Med Sci.
- 2002 Jun;17(3):348-352.
- doi: 10.3346/jkms.2002.17.3.348
To evaluate the activity and safety of a combination chemotherapy with epirubicin, cisplatin, and a protracted venous infusion of 5-fluorouracil (ECF) in unresectable or metastatic gastric cancer, a phase II... -
- CITED
-
- Close
- SHARE
-
- Close
